Judd, Kelsie

Judd, Kelsie was paid $91K by Medicaid between Sep 2020 and Dec 2022, across 7 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 56% of everything it billed.

33Billing provider infoJUDD, KELSIE
MILFORD, PA 18337

33aNPI1912460668assigned 04/10/2019

33bProvider typePrimary Care Nurse Practitioner

28Total paid$91K

24GClaims1,004

24DCodes billed7

24AFirst – last monthSep 2020 – Dec 2022

Compared with peers

Next to other Primary Care Nurse Practitioner providers in Pennsylvania

Rank by total paid#8 of 55

Median peer was paid$9K

This provider vs. median10.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	138	$7K
2021	526	$52K
2022	340	$32K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	56%	479	449	$51K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	40%	447	432	$36K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	2.0%	13	13	$2K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.3%	19	19	$1K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	19	19	$400.00
90686		<1%	14	14	$227.76
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	13	13	$130.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.